Holders

BRIDGEBIO PHARMA INC

Q4 2024 13F holders

CUSIP
10806XAD4
Type
Debt
Class
NOTE 2.250% 2/0
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Principal Option type